check_circleStudy Completed

Dermatomycoses

Bayer Identifier:

Trial_0219

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Study of BAYB5097 Solution N to test the efficacy and tolerability in subjects with dermatomycoses

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

Both

Age

15 - 71 Years
  • -

  • -

Trial summary

Enrollment Goal
35
Trial Dates
November 1974 - February 1976
Phase
N/A
Could I Receive a placebo
N/A
Products
Mycelex (Clotrimazole, BAYB5097)
Accepts Healthy Volunteer
N/A

Trial design

Open label, mycologically controlled study of BAYB5097 Solution N to test the efficacy and tolerability in subjects with dermatomycoses.
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A